Past Advances in Cell & Tissue Culture Conferences
ACTC has been running events for 10 years with growing success. ACTC is a forum for leading researchers to present their work on in vitro cell culture and is a great opportunity for the exchanging of ideas. It is a ‘Gordon Style’ event, encouraging everybody to contribute.
ACTC 2018 – CARDIFF
ACTC 2018 Programme
In Vitro Models for the Study of Neurological Diseases Chair: Professor Roxana O Carare (University of Southampton)
Creating More Realistic Gut Models Chair: Professor Julian Marchesi (Imperial College London and Cardiff University)
Advanced Cell Culture: 3D, Fluid Flow and Co-culture Chair: Professor Trevor Dale (Cardiff University)
In Vitro Models for Animal Replacement Chair: Dr Gerry Kenna (Safer Medicines Trust)
Stem Cells: Developing Off the Shelf Therapeutics Chair: Dr Pascale V Guillot (University College London, UK)
ACTC 2018 Keynote Speakers
Geoff Pilkington (University of Portsmouth)
Dr Christophe Lacroix (Laboratory of Food Biotechnology, ETH Zurich)
Dr Dominic Williams (AstraZeneca)
Dr Murat Cirit (Massachusetts Institute of Technology)
Dr Paul Walker (Cyprotex)
Professor Tommy Andersson (AstraZeneca)
Dr Hassan Rashidi (UCL)
ACTC 2017 – MANCHESTER
The 2017 conference was held at the Macdonald Hotel in Manchester, UK.
ACTC 2017 Programme
In vitro models for animal replacement Chair: Dr Brett Cochrane (Dr Hadwen Trust, UK)
In vitro to in vivo extrapolation Chair: Dr Harvey Clewell (ScitoVation, USA)
Safety and toxicology Chair: Dr Phil Hewitt (Merck, Germany)
Tissue Engineering Chair: Professor Jamie Davies (University of Edinburgh, UK)
Bioreactors, 3D and dynamic flow Chair: Professor Sarah Cartmell (University of Manchester, UK)
Disease modelling and co-culture Chair: Dr Pascale V Guillot (University College London, UK)
Cultivating Cells under Physiological Conditions Chair: Dr Beate Rinner (Medical University of Graz, Austria)
ACTC 2017 Keynote Speakers
Dr Harvey Clewell (ScitoVation, USA)
Harvey’s work involves combining state-of-the art modeling of tissue dosimetry and cellular response with targeted in vitro studies, in order to reduce the uncertainty in estimates of the effects of environmental chemicals, personal care products, food ingredients and pharmaceuticals in humans.
Professor Mark Cronin (Liverpool John Moores University, UK)
Mark Cronin is Professor of Predictive Toxicology in the School of Pharmacy and Chemistry at Liverpool John Moores University, England. He has research interests in the development of in silico approaches to predict the toxicity and fate of chemicals. This includes both environmental and human health endpoints.
It was an ideal opportunity for my student, a junior researcher, to present some of her work in a supportive and sociable environment that is perhaps not quite as daunting as a large conference. Also, for me as a primary investigator to talk to other people working in the field. It is a very useful meeting to come to!
The ACTC conference is an excellent place to meet colleagues and hear inspiring presentations in a relaxed informal atmosphere. The science is front and center, and there is always something fresh and new to learn/discuss. There is a healthy mix of experiences scientists from academia and industry together with many young aspiring scientists!
ACTC is a small but well-attended conference providing opportunity for academic, industrial and commercial scientists to share ideas, technological advances and future visions in the field of bioreactors, human on a chip and 3Rs. This conference was a great platform to share current research and develop collaborations to drive forward the innovative use of advanced cell culture techniques and models. Overall, a well organised, interesting and relevant conference.